Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2010-08-12 Management Reports
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
6-Monatsbericht 2010
Management Reports Classification · 99% confidence The document is titled "Lagebericht für das erste Halbjahr 2010" (Management Report for the First Half of 2010) and contains detailed financial performance metrics, operational highlights, updates on research alliances, pipeline progress, and management changes for the first six months of the year. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). The length (over 90,000 characters) confirms it is a detailed report, not just an announcement (RPA/RNS).
2010-08-12 German
Q2 Report 2010
Management Reports Classification · 99% confidence The document is explicitly titled "Management Report of the First Half of 2010" and contains detailed operational performance reviews, updates on discovery alliances, pipeline progress, management changes, and a section titled "A. REPORT ON THE FINANCIAL SITUATION AND RESULTS" covering revenues for the first half of 2010. This structure—a comprehensive report covering a period shorter than a full year (H1 2010) with detailed financial and operational commentary—is characteristic of an Interim/Quarterly Report (IR). It is not a brief announcement (RPA/RNS) because it contains the full substance of the report, nor is it the Annual Report (10-K).
2010-08-12 English
H1-2010_Presentation
Investor Presentation Classification · 100% confidence The document is titled 'H1 2010 Results – Strongest H1 in Company History' and is explicitly labeled as an 'Evotec AG, H1 Presentation'. It contains financial highlights, strategic updates, and forward-looking statements typical of an investor presentation delivered during an earnings period. It is not a full interim report (which would be a formal financial filing) but rather a slide deck used to present these results to investors. H1 2010
2010-08-11 English
Hauptversammlung 2010
AGM Information Classification · 98% confidence The document text is titled "Ordentliche Hauptversammlung 2010" (Annual General Meeting 2010) and contains an agenda that includes sections like "Begrüßung und Vorstellung" (Welcome and Introduction), a review of past performance ("Was wir bis heute erreicht haben" including "Konzernabschluss 2009"), and future outlook ("Wohin wir gehen wollen"). The structure, the explicit mention of the 'Hauptversammlung' (General Meeting), and the presentation format strongly indicate materials related to the Annual General Meeting. Although it references the 2009 Annual Report ('Konzernabschluss 2009'), the document itself is the presentation or material used *at* the meeting, not the full 10-K or a standalone Audit Report. Therefore, the most appropriate classification is AGM Information (AGM-R).
2010-06-09 German
Q1 Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management Report of the First Quarter 2010' and provides a detailed breakdown of financial performance, operational highlights, and clinical program status for the specified period. It contains substantive financial data, including revenue growth, operating loss figures, and cash flow analysis. As it is a comprehensive report for a period shorter than a full fiscal year, it fits the definition of an Interim/Quarterly Report (IR). Q1 2010
2010-05-12 German
Q1-2010_Presentation
Investor Presentation Classification · 98% confidence The document is titled "Evotec AG, Q1 Update Presentation, 12 May 2010" and contains sections like "Q1 Highlights," "Financials & Outlook," and details about strategic alliances and drug discovery progress. The structure, use of slides/pages, and focus on quarterly performance updates strongly indicate this is an Investor Presentation (IP) or a presentation accompanying an earnings release. Since it is explicitly labeled as a 'Presentation' and details strategy and financials for a specific period (Q1), 'Investor Presentation' (IP) is the most accurate classification, rather than the formal Earnings Release (ER) or the comprehensive Interim Report (IR).
2010-05-11 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.